BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11870339)

  • 1. Distortion-product otoacoustic emissions in nonacoustic tumors of the cerebellopontine angle.
    Mobley SR; Odabasi O; Ahsan S; Martin G; Stagner B; Telischi FF
    Otolaryngol Head Neck Surg; 2002 Feb; 126(2):115-20. PubMed ID: 11870339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative monitoring of cochlear function using distortion product otoacoustic emissions (DPOAEs) in patients with cerebellopontine angle tumors.
    Morawski K; Namyslowski G; Lisowska G; Bazowski P; Kwiek S; Telischi FF
    Otol Neurotol; 2004 Sep; 25(5):818-25. PubMed ID: 15354017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acoustic tumor extension into the internal auditory canal on distortion-product otoacoustic emissions.
    Odabasi AO; Telischi FF; Gomez-Marin O; Stagner B; Martin G
    Ann Otol Rhinol Laryngol; 2002 Oct; 111(10):912-5. PubMed ID: 12389860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early effects of cerebellopontine angle compression on rabbit distortion-product otoacoustic emissions: a model for monitoring cochlear function during acoustic neuroma surgery.
    Widick MP; Telischi FF; Lonsbury-Martin BL; Stagner BB
    Otolaryngol Head Neck Surg; 1994 Oct; 111(4):407-16. PubMed ID: 7936673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasospasm of labyrinthine artery in cerebellopontine angle surgery: evidence brought by distortion-product otoacoustic emissions.
    Mom T; Montalban A; Khalil T; Gabrillargues J; Chazal J; Gilain L; Avan P
    Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2627-35. PubMed ID: 24114065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of cochlear function with distortion products of otoacoustic emissions in acoustic neuroma].
    Oeken J
    HNO; 1996 Dec; 44(12):677-84. PubMed ID: 9081952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distortion-product otoacoustic emission tests evaluate cochlear function and differentiate cochlear and vestibular schwannoma.
    Kagoya R; Shinogami M; Kohno M; Yamasoba T
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):267-71. PubMed ID: 23197675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracochlear signal in FIESTA-C and hearings of patients with cerebellopontine angle schwannoma.
    Kitamura M; Oishi N; Nishiyama T; Hosoya M; Hasebe N; Tsuzuki N; Ogawa K
    Acta Otolaryngol; 2023 Jan; 143(1):19-23. PubMed ID: 36661412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brainstem auditory evoked potentials in patients with cerebellopontine angle tumors.
    Møller MB; Møller AR
    Ann Otol Rhinol Laryngol; 1983; 92(6 Pt 1):645-50. PubMed ID: 6607018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased amplitudes of distortion product otoacoustic emissions in patients with unilateral acoustic neuroma.
    Gouveris H; Mann W
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):302-5. PubMed ID: 15668528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of the clinical profile and referral pattern differences of vestibular schwannomas and other cerebellopontine angle tumors.
    Ragab A; Emara A; Shouker M; Ebied O
    Otol Neurotol; 2012 Jul; 33(5):863-70. PubMed ID: 22664901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distortion product otoacoustic emissions and tympanometric measurements in an adult population-based study.
    Uchida Y; Ando F; Nakata S; Ueda H; Nakashima T; Niino N; Shimokata H
    Auris Nasus Larynx; 2006 Dec; 33(4):397-401. PubMed ID: 16753276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory brain stem response wave IV-V abnormalities from the ear opposite large cerebellopontine lesions.
    Musiek FE; Kibbe K
    Am J Otol; 1986 Jul; 7(4):253-7. PubMed ID: 3488689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency distortion product otoacoustic emissions in children with and without middle ear dysfunction.
    Kei J; Brazel B; Crebbin K; Richards A; Willeston N
    Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):125-33. PubMed ID: 17126413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.